Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.74 USD | +1.02% | +5.88% | +6.73% |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Apr. 23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.73% | 1.32B | |
-3.17% | 102B | |
+1.65% | 96.29B | |
+2.13% | 22.18B | |
-15.86% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.77% | 16.36B | |
+5.06% | 13.97B | |
+32.61% | 12.17B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Wedbush Adjusts Kiniksa Pharmaceuticals' PT to $30 From $28, Maintains Outperform Rating